Skip to Main Content

Author Details

Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
1987
31
23
PMIDPaper TitleJournal TitlePublished Year
32211329CAMKV Is a Candidate Immunotherapeutic Target in <i>MYCN</i> Amplified Neuroblastoma.Front Oncol2020
32029721Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia.Cell Death Dis2020
32307821Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma.Pediatr Blood Cancer2020
31693904Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.Cell Rep2019
27729458Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.Clin Cancer Res2017
28350380Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.Sci Data2017
29206221Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.Sci Data2017
27986745Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against Neuroblastoma.Clin Cancer Res2017
26121087Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.Nat Genet2015
26560027Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.Nature2015
24569374Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma.J Clin Invest2014
23849696Inhibition of Hsp27 radiosensitizes head-and-neck cancer by modulating deoxyribonucleic acid repair.Int J Radiat Oncol Biol Phys2013
24045179Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.Clin Cancer Res2013
23143306ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth.J Clin Invest2012
21646472Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.Cancer Res2011
21975022High-resolution imaging and antitumor effects of GFP(+) bone marrow-derived cells homing to syngeneic mouse colon tumors.Am J Pathol2011
21720213Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab.Cell Cycle2011
21653830Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation.Sci Transl Med2011
20473272The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.EMBO J2010
19632170Cell death: a new Par-4 the TRAIL.Cell2009
19923910The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells.Cancer Biol Ther2009
19923899Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.Cancer Biol Ther2009
20054236The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.Cell Cycle2009
18182481OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells.Mol Pharmacol2008
18539971Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells.J Clin Oncol2008
17172468The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage.J Biol Chem2007
17912032Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines.Cell Cycle2007
17881904Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4.Cancer Biol Ther2007
16704987Arachidonic acid-induced gene expression in colon cancer cells.Carcinogenesis2006
15507430The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner.J Biol Chem2005
3574053Plasma beta-endorphin responses to one-hour bicycling and running at 60% VO2max.Med Sci Sports Exerc1987
  • 1 - 31 of 31

Recommended Authors

Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 1
Evangelos Pazarentzos
University of California san francisco
Career Start Year 2011
Number of shared co-authors 0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 2
Jordi Carreras Puigvert
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2009
Number of shared co-authors 1
Juan L Callejas-Valera
Cancer Biology Research Center
Career Start Year 2008
Number of shared co-authors 0
Nina Fenouille
Universite Paris Cite, INSERM, CNRS
Career Start Year 2008
Number of shared co-authors 0
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 3
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 2
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 5
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 1
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1998
Number of shared co-authors 1
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 2
Andrei Goga
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 2
Jan Paul Medema
Oncode Institute
Career Start Year 1993
Number of shared co-authors 2
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 16
Linda Z Penn
University of Toronto
Career Start Year 1990
Number of shared co-authors 3
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Career Start Year 1990
Number of shared co-authors 1
Poul H Sorensen
British Columbia Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 12
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 9
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 5
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 7
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 4
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 13
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 3
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 15

Collaborators

John M Maris
Children's Hospital of Philadelphia
Co-authored papers 10
Sharon J Diskin
Children's Hospital of Philadelphia
Co-authored papers 4
Maura Diamond
Co-authored papers 3
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 3
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 3
Charles Patrick Reynolds
Cancer Center, Texas Tech University Health Sciences Center
Co-authored papers 3
Giordano Caponigro
Co-authored papers 3
Sunkyu Kim
Korea University
Co-authored papers 3
Yimei Li
Co-authored papers 3
Yael P Mosse
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 2
Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 2
Alvin Farrel
Children's Hospital of Philadelphia
Co-authored papers 2
Javed Khan
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Jun S Wei
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
John Alan Diehl
Case Western Reserve University School of Medicine
Co-authored papers 2
Joshua E Allen
Co-authored papers 2
Daniela S Gerhard
National Cancer Institute
Co-authored papers 2
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Malcolm A Smith
National Cancer Institute
Co-authored papers 2
Jaime M Guidry Auvil
National Cancer Institute
Co-authored papers 2
Julie M Gastier-Foster
Baylor College of Medicine
Co-authored papers 2
Kateryna Krytska
University of Pennsylvania Perelman School of Medicine
Co-authored papers 2
Shizhen Zhu
Co-authored papers 1
Harshavardhan Doddapaneni
Baylor College of Medicine
Co-authored papers 1
Xiao-Nan Li
Northwestern University
Co-authored papers 1
Holly Lindsay
Texas Children's Cancer Center, Baylor College of Medicine
Co-authored papers 1
Ulrike M Litzenburger
Center for Personal Dynamic Regulomes, Stanford University School of Medicine
Co-authored papers 1
Dias Kurmashev
Greehey Children's Cancer Research Institute
Co-authored papers 1
Johannes H Schulte
Co-authored papers 1
Maria V Lane
Co-authored papers 1
Release 1.2